Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
Montelukast
PCO Manufacturing Ltd.
R03DC; R03DC03
Montelukast
10 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Leukotriene receptor antagonists; montelukast
Authorised
2004-03-19
_ _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE USER SINGULAIR ® 10 MG FILM-COATED TABLETS montelukast READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Singulair is and what it is used for 2. What you need to know before you take Singulair 3. How to take Singulair 4. Possible side effects 5. How to store Singulair 6. Contents of the pack and other information 1. WHAT SINGULAIR IS AND WHAT IT IS USED FOR WHAT Singulair IS Singulair is a leukotriene receptor antagonist that blocks substances called leukotrienes. HOW SINGULAIR WORKS Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms. By blocking leukotrienes, Singulair improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis). WHEN SINGULAIR SHOULD BE USED Your doctor has prescribed Singulair to treat asthma, preventing your asthma symptoms during the day and night. • Singulair is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled on their medication and need additional therapy. • Singulair also helps prevent the narrowing of airways triggered by exercise. • In those asthmatic patients in whom Singulair is indicated in asthma, Singulair can also provide symptomatic relief of seasonal allergic rhinitis. Your doctor will determine how Singulair should be used depending on the symptoms and severity of your asthma. WHAT IS ASTHMA? Asthma is a long-term di Baca dokumen lengkap
Health Products Regulatory Authority 17 July 2023 CRN00DPP0 Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Singulair 10 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains montelukast sodium, which is equivalent to 10 mg montelukast. Excipient(s) with known effect: lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _ _ _Product sourced from Portugal, Italy, Poland, Belgium and Czech Republic:_ Beige, rounded square, film-coated tablet with 'SINGULAIR' engraved on one side and 'MSD 117' on the other. or _ _ _Product sourced from Italy:_ Beige, rounded square, film coated tablet with '117' engraved on one side. 4 CLINICAL PARTICULARS As per PA23198/014/004 5 PHARMACOLOGICAL PROPERTIES As per PA23198/014/004 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Microcrystalline cellulose Lactose monohydrate Croscarmellose sodium Hyprolose (E 463) Magnesium stearate Film coating: Hypromellose Hyprolose (E 463) Titanium dioxide (E 171) Red and yellow ferric oxide (E 172) Carnauba wax 6.2 INCOMPATIBILITIES Not applicable Health Products Regulatory Authority 17 July 2023 CRN00DPP0 Page 2 of 2 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30 °C. Store in the original package in order to protect from light and moisture. 6.5 NATURE AND CONTENTS OF CONTAINER Blister pack of 28 tablets in a cardboard carton. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL Any unused medicinal product or waste material should be disposed of in accordance with local requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/111/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authoris Baca dokumen lengkap